Blog
RSS FeedPosted by Michael Wonder on 05 Aug 2015
NICE set to recommend another leukaemia drug
NICE has issued further draft guidance for consultation that recommends obinutuzumab, marketed by Roche as Gazyvaro, for some people with ...
Posted by Michael Wonder on 05 Aug 2015
Agenda for 3 December 2014 Transparency Committee meeting
The agenda for the 3 December 2014 Transparency Commission meeting is now available. The Commission will consider the following medicines: ...